Results 51 to 60 of about 154 (61)

Upfront blood microRNA test in LDCT-reluctant individuals: insights from the biomild trial. [PDF]

open access: yesJ Exp Clin Cancer Res
Sozzi G   +9 more
europepmc   +1 more source

From multi-omics to deep learning: advances in cfDNA-based liquid biopsy for multi-cancer screening. [PDF]

open access: yesBiomark Res
Luo X   +13 more
europepmc   +1 more source

The role of circulating tumor DNA in gynecological cancer management. [PDF]

open access: yesFront Oncol
Gao M   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles

Molecular and Cellular Probes, 2022
Hyun-Ju Cho
exaly  

Quantitative Fragmentome Mapping Reveals Novel, Domain-specific Partners for the Modular Protein RepoMan (Recruits PP1 Onto Mitotic Chromatin at Anaphase)

Molecular and Cellular Proteomics, 2013
Delphine Chamousset   +2 more
exaly  

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection—Letter

Cancer Discovery
Martin Tammemagi, Tammemagi Martin C
exaly  

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection—Reply

Cancer Discovery
Peter Bach   +2 more
exaly  

Abstract 1125: Characterizing the cfDNA fragmentome in patients with hepatocellular carcinoma

Cancer Research
exaly  

Early Diagnosis of Lung Cancer by Detecting Tumor Originated Deoxyribo Nucleic Acid (DNA) Fragments Using Plasma Cell-free DNA Methylome and Fragmentome Profiles

Y -C Kim, I -J Oh, H ‐J Cho
exaly  

Abstract 109: Integrative analyses of the cfDNA fragmentome and TCR repertoires capture chemo-immunotherapy response in diffuse pleural mesothelioma.

Cancer Research
exaly  
liquid biopsy
cfdna
fragmentomics
previous   4  5  6  7  

Home - About - Disclaimer - Privacy